These medications work by mimicking the action of the naturally occurring GLP-1 hormone, which is released from the intestine in response to food intake
Its application in diabetes operates through a different pathway: it is thought to reset circadian rhythms in the hypothalamus, which regulate, among other things, daily blood glucose patterns (Shivaprasad & Kalra, 2011)
Companion digital solutions can help users develop new behaviors to ensure theyve made a change that will stick for good. Marni Allen, CMO, Bioniq PepsiCo: Negligible impact At PepsiCo, so far at least, the impact of GLP-1 drugs has been negligible, CEO Ramon Laguarta told analysts during the firms latest earnings call
GLP-1 agonist medications have been on the market since 2005 with the release of exenatide (Byetta, AstraZeneca)